Dexamethasone: all 1,888 studies that test it
Page 16 of 19. Open to participants first (285), then studies with results posted, then the rest; newest registration first within each.
- Sudden Hearing Loss Multi-center Clinical TrialStatus unknownNCT02026479Not applicable
- Prevention of Nausea and Vomiting in Patients After SurgeryCompletedNCT02021851Phase 4
- Ketamine in Post-operative Dental Pain and RecoveryCompletedNCT02021240Phase 3
- The Effect of Dexamethasone on the Duration and Functionality of Bupivacaine Intercostal Nerve BlockadeStatus unknownNCT02005575Phase 4
- A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple MyelomaCompletedNCT01998971Phase 1
- GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell LymphomaStatus unknownNCT01991158Phase 2
- Effect of Intravenous Lidocaine and Dexamethasone Combination on Postoperative Sore Throat, Cough and Hoarseness.CompletedNCT01990781Phase 4
- Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple MyelomaTerminatedNCT01985477Phase 1
- Dexamethasone for the Treatment of Established Postoperative Nausea and VomitingTerminatedNCT01975727Phase 2
- A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple MyelomaCompletedNCT01965353Phase 1
- The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine SurgeryCompletedNCT01953978Phase 4
- Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGFTerminatedNCT01946399Not applicable
- The Value of Short-term Pain Relief for the Prediction of Long-term Outcome After Cervical or Lumbar Nerve Root InfiltrationCompletedNCT01945554Not applicable
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic CholangiocarcinomaCompletedNCT01938729Phase 1
- Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)CompletedNCT01936532Phase 2
- Avastin+ GemAOD As First-Line Treatment in NK/T Cell LymphomaStatus unknownNCT01921790Phase 2
- Low-dose Dexamethasone in Newly Diagnosed Pulmonary SarcoidosisStatus unknownNCT01920919Phase 3
- A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic LeukemiaActive, not recruitingNCT01920737Phase 2
- Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.Status unknownNCT01913990Phase 4
- Maintenance Therapy With Subcutaneous BortezomibCompletedNCT01913730Phase 2
- Study to Evaluate Optimized Retreatment and Prolonged Therapy With BortezomibCompletedNCT01910987Phase 3
- A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis ExternaTerminatedNCT01910155Phase 3
- A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell LymphomaTerminatedNCT01878708Early Phase 1
- Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and VomitingCompletedNCT01876290Phase 4
- Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)CompletedNCT01868269Phase 3
- Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaActive, not recruitingNCT01863550Phase 3
- Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)CompletedNCT01857115Phase 1/2
- Ovulation Induction With Clomiphene Citrate and DexamethasoneStatus unknownNCT01856062Phase 4
- Comparison of Efficacy of Nebulizing Budesonide and Intravenous Dexamethasone Before Extubation on Prevention of Post-extubation Complications in Intensive Care Unit PatientsStatus unknownNCT01854515Not applicable
- Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell LymphomaCompletedNCT01846390Phase 1
- Epinephrine, Dexamethasone, and Hypertonic Saline in Bronchiolitis, Randomised Clinical Trial of Efficacy and SafetyCompletedNCT01834820Phase 4
- Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein OcclusionStatus unknownNCT01827722Phase 4
- Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS SyndromeCompletedNCT01816620Phase 2
- Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell TransplantWithdrawnNCT01812720Phase 2
- Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL AmyloidosisTerminatedNCT01807286Phase 1
- Comparison of Two Regimens of Dexamethasone in the Prevention of Hypersensitivity Reactions to Paclitaxel, a Pilot StudyCompletedNCT01797991Not applicable
- A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard TherapyCompletedNCT01794507Phase 1
- Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Progressive Multiple MyelomaStatus unknownNCT01792102Phase 1/2
- Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's MacroglobulinemiaCompletedNCT01788020Phase 3
- Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01787669Phase 2
- PRevention of Macular EDema After Cataract SurgeryCompletedNCT01774474Phase 3
- Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean Section in Term FetusCompletedNCT01772381Not applicable
- Dexamethasone for Excessive MenstruationCompletedNCT01769820Phase 2
- SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM PatientsCompletedNCT01749969Phase 1
- Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)CompletedNCT01745640Phase 2
- Santeon-CAP; Dexamethasone in Community-acquired PneumoniaTerminatedNCT01743755Phase 4
- Postoperative Vomiting in Children: Comparison Tri - Versus bi -ProphylaxisCompletedNCT01739985Not applicable
- Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress SyndromeCompletedNCT01731795Phase 4
- First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDDTerminatedNCT01728259Phase 1
- Comparison the Effects of Dexamethasone and Loteprednol on Epithelial HealingCompletedNCT01724892Phase 4
- Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular LymphomaCompletedNCT01722305Phase 1
- Validation of a Lung Inflammation Model in Healthy Volunteers by Radiological Tools and Glucocorticoid TreatmentCompletedNCT01714427Not applicable
- Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaCompletedNCT01711528Phase 1
- A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal MembranesStatus unknownNCT01701518Not applicable
- Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host DiseaseCompletedNCT01699412Phase 3
- Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular EdemaCompletedNCT01698788Not applicable
- Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular EdemaCompletedNCT01698749Not applicable
- Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01689987Phase 1
- Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed MyelomaStatus unknownNCT01686386Phase 1/2
- Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple MyelomaWithdrawnNCT01680796Phase 1
- Antagonism Research Between Antiemetics Agents and Acetaminophen in Thyroidectomy's Post-operative Analgesia.CompletedNCT01679093Phase 3
- Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary MeasuresCompletedNCT01673087Phase 1
- Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009CompletedNCT01669499Phase 3
- Efficacy of Aprepitant (Emend®) in ChildrenCompletedNCT01661335Phase 3
- MLN9708 and Dexamethasone for High-Risk Smoldering Multiple MyelomaWithdrawnNCT01660997Phase 2
- A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed MyelomaCompletedNCT01660750Phase 1
- Eltrombopag and High-dose Dexamethasone as First Line Treatment for ITCompletedNCT01652599Phase 2
- Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib MaintenanceWithdrawnNCT01647165Phase 2
- Trial Comparing Duration of Analgesia After Popliteal Fossa Sciatiac Nerve Block With Ropivacaine 0.5% When Combined With Placebo, Dexamethasone 4mg or Dexamethasone 8 mgWithdrawnNCT01641419Not applicable
- POEMS Syndrome Treatment With LenalidomideCompletedNCT01639898Phase 2
- Effect of Dexamethasone and Methylprednisolone on Pain, Swelling and Trismus After Third Molar SurgeryCompletedNCT01603498Not applicable
- Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple MyelomaCompletedNCT01593410Phase 2
- Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple MyelomaCompletedNCT01583283Phase 1
- Vorinostat Plus FND in Relapsed or Refractory Mantle Cell LymphomaTerminatedNCT01578343Phase 2
- Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)CompletedNCT01575925Phase 1
- Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin LymphomaCompletedNCT01569204Phase 2
- Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCLCompletedNCT01562977Phase 2
- Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple MyelomaActive, not recruitingNCT01562405Phase 1
- Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple MyelomaTerminatedNCT01555281Phase 1/2
- Lenalidomide and Dexamethasone in Primary Plasma Cell LeukemiaCompletedNCT01553357Phase 2
- Single Dose of Dexamethasone in Femur FracturesStatus unknownNCT01550146Phase 4
- Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic LaparoscopyCompletedNCT01543945Phase 2
- Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple MyelomaStatus unknownNCT01541332Phase 1/2
- Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene BlockWithdrawnNCT01538459Phase 3
- Function of Regulatory T Cells Improved by Dexamethasone in Graves' PatientsCompletedNCT01534169Phase 1
- Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 YearsStatus unknownNCT01532856Phase 3
- Risk-adapted Therapy for Primary Systemic (AL) AmyloidosisCompletedNCT01527032Phase 2
- Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MMCompletedNCT01526694Phase 2
- The Effect of Prophylactic Antiemetic Dexamethasone on Plasma Cortisol LevelsCompletedNCT01524731Not applicable
- Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple MyelomaStatus unknownNCT01522872Phase 1/2
- Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple MyelomaTerminatedNCT01518465Phase 2
- Duration of Leg Nerve Blocks With Dexamethasone Added to Local AnestheticWithdrawnNCT01511211Phase 4
- Pomalidomide and Dexamethasone (PDex) in AL AmyloidosisCompletedNCT01510613Phase 2
- Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaCompletedNCT01497093Phase 1
- A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral ConjunctivitisCompletedNCT01481519Phase 3
- ACVDL Treatment for Patients With Newly Diagnosed Multiple MyelomaCompletedNCT01481194Phase 2
- Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic RetinopathyCompletedNCT01478737Phase 2
- A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT01464034Phase 1/2
- Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL)CompletedNCT01459211Phase 2
- Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment TrialWithdrawnNCT01442428Phase 2/3